Pictet Asset Management (Switzerland)’s Regeneron Pharmaceuticals REGN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$303M	Sell	421,772 -7,131	-2%	-$5.5M	0.36%	79
2023 Q1	$352M	Buy	428,903 +120,037	+39%	+$90.5M	0.44%	55
2022 Q4	$178M	Sell	308,866 -37,648	-11%	-$27.8M	0.26%	117
2022 Q3	$239M	Buy	346,514 +84,405	+32%	+$53.1M	0.35%	75
2022 Q2	$155M	Sell	262,109 -62,550	-19%	-$40.7M	0.22%	143
2022 Q1	$227M	Sell	324,659 -24,467	-7%	-$15.5M	0.26%	121
2021 Q4	$220M	Sell	349,126 -108,764	-24%	-$66.9M	0.22%	139
2021 Q3	$277M	Buy	+457,890	New	+$284M	0.31%	92

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s REGN Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q2 2023, selling an estimated $5.5M and leaving 421,772 shares worth $303M. The position accounts for 0.36% of the portfolio, ranked #79.

Pictet Asset Management (Switzerland) first reported a position in REGN in Q3 2021 and has held it in 8 quarters since. The position peaked at $352M in Q1 2023. 1,166 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

Pictet Asset Management (Switzerland) held 421,772 shares of Regeneron Pharmaceuticals worth $303M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 7,131 Regeneron Pharmaceuticals shares in Q2 2023, an estimated $5.5M.
Regeneron Pharmaceuticals made up 0.36% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #79 holding.
Pictet Asset Management (Switzerland) first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Regeneron Pharmaceuticals position peaked at $352M in Q1 2023.
1,166 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.